While neither GIP nor glucagon seem to exert sufficient individual effects to justify their clinical use in the treatment of type 2 diabetes and obesity, the combination of these hormones with GLP-1 may represent a new treatment strategy in the near future
Last month, the administration told states that these services, which can also include high-speed internet and storage units, should not be part of Medicaid
The drug warning label for Ozempic was changed in March 2022 to include a specific warning about gallbladder disease
It is designed for skin glowing purposes
Originally developed to treat type 2 diabetes, the drugs now are also widely used to lose weight
However, it is noteworthy that these drugs, albeit similar, are not interchangeable and should be administered under proper medical supervision